MUC1 and pancreatic intraductal papillary-mucinous neoplasm: To characterize the cystic lesions, we performed immunohistochemistry and found strong expression of MUC1 and MUC5 and weak expression of MUC2, which are markers of the pancreatobiliary and oncocytic IPMN types in humans (Fig. 2C).